Reduce costs, improve investigator experience and accelerate clinical trials.
The COVID-19 pandemic has changed the clinical trial landscape.
Cognizant® Shared Investigator Platform (SIP) provides a way forward, enabling sponsors to meet the challenges of the current environment while providing a better trial experience to clinical researchers.
Cognizant SIP is a cloud-based solution, built and developed by a consortium of leading biopharmaceutical companies that came together to share information and standardize workflows. As the industry’s premier clinical trials operations platform, Cognizant SIP provides a single point of access for clinical trial stakeholders, transforming how sponsors and sites collaborate. Site selection, communications and management are all hosted on a secure platform tailored for the needs of sites and investigators.
Cognizant SIP streamlines and decentralizes the trial process. Equally important, it provides new conveniences that dramatically improve the experience for investigators and reduce clinical trial cycle times.